| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| SULENTIC ROBERT E | Chair & CEO, Director | 2121 NORTH PEARL STREET, SUITE 300, DALLAS | /s/ Andria Iles, Attorney-in-Fact for Robert E. Sulentic | 24 Feb 2026 | 0001190868 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CBRE | Class A Common Stock | Award | $0 | +84,094 | +6.6% | $0.000000 | 1,348,748 | 20 Feb 2026 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Represents restricted stock units granted to the Reporting Person on March 5, 2025 as part of the Reporting Person's 2025 annual equity award. On February 20, 2026, the Compensation Committee of the Board of Directors of the Issuer certified the Issuer's Core EPS performance necessary for this award to vest. As such, these restricted stock units will vest in full on March 5, 2028, subject to forfeiture in certain circumstances as set forth in the restricted stock units award agreement. |